Delivery Order SPE2DB20D1109-SPE2DB23FP65X
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm fixed price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used to treat diabetes. The contract has an ultimate completion date of March 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,401.80 firm fixed-price delivery order is for the supply of Lantus Solostar, a 100 unit/mL insulin product, with a performance period through January 19, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Lantus Solostar 100 unit/ml 3ml insulin products to the Defense Logistics Agency (DLA). The $8,907 firm-fixed price delivery order contract has a period of performance through September 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for a broad range of medical commodities to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,707.66 firm-fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract has a period of performance through June 23, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $3,258.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The contract covers the delivery of Lantus Solostar, a 100 unit/mL, 3mL insulin product, to support military healthcare programs. The contract does not have a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,592.83 firm fixed-price delivery order is for the supply of Lantus Solostar 100 Unit/ML 3ML, a specialty medication. The contract has an ultimate completion date of July 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,448.08, is for the delivery of Lantus Solostar 100 unit/mL 3mL, a prescription insulin product, to support federal healthcare programs. The contract was awarded as a Delivery Order without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Lantus Solostar 100 unit/ml 3ml insulin medication. The $2,275.20 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,122.58 firm-fixed-price delivery order is for Lantus Solostar 100 unit/mL 3mL, a specialty medication used to treat diabetes. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The $2,527.66 firm fixed-price delivery order is for the supply of Lantus Solostar 100 Unit/mL 3mL, a prescription insulin product. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen, through its Corporate Office division, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP65XDelivery Order
This federal contract award, valued at $2,383.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a specialty insulin medication, to support military healthcare programs. This is a Firm Fixed Price Delivery Order with an ultimate completion date of August 3, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/2/23 |